Literature DB >> 28505592

Human norovirus inhibition by a human milk oligosaccharide.

Anna Koromyslova1, Shailesh Tripathi1, Vasily Morozov2, Horst Schroten3, Grant S Hansman4.   

Abstract

Human noroviruses are the leading cause of outbreaks of acute gastroenteritis. Norovirus interactions with histo-blood group antigens (HBGAs) are known to be important for an infection. In this study, we identified the HBGA binding pocket for an emerging GII genotype 17 (GII.17) variant using X-ray crystallography. The GII.17 variant bound the HBGA with an equivalent set of residues as the leading pandemic GII.4 variants. These structural data highlights the conserved nature of HBGA binding site between prevalent GII noroviruses. Noroviruses also interact with human milk oligosaccharides (HMOs), which mimic HBGAs and may function as receptor decoys. We previously showed that HMOs inhibited the binding of rarely detected GII.10 norovirus to HBGAs. We now found that an HMO, 2'-fucosyllactose (2'FL), additionally blocked both the GI.1 and GII.17 noroviruses from binding to HBGAs. Together, these findings provide evidence that 2'FL might function as a broadly reactive antiviral against multiple norovirus genogroups.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Histo-blood group antigens; Human milk oligosaccharides; Norovirus

Mesh:

Substances:

Year:  2017        PMID: 28505592     DOI: 10.1016/j.virol.2017.04.032

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  48 in total

1.  Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.

Authors:  Anna D Koromyslova; Jessica M Devant; Turgay Kilic; Charles D Sabin; Virginie Malak; Grant S Hansman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Avidity of α-fucose on human milk oligosaccharides and blood group-unrelated oligo/polyfucoses is essential for potent norovirus-binding targets.

Authors:  Franz-Georg Hanisch; Grant S Hansman; Vasily Morozov; Clemens Kunz; Horst Schroten
Journal:  J Biol Chem       Date:  2018-06-01       Impact factor: 5.157

Review 3.  The Human Milk Glycome as a Defense Against Infectious Diseases: Rationale, Challenges, and Opportunities.

Authors:  Kelly M Craft; Steven D Townsend
Journal:  ACS Infect Dis       Date:  2017-11-15       Impact factor: 5.084

4.  Atomic Structure of the Murine Norovirus Protruding Domain and Soluble CD300lf Receptor Complex.

Authors:  Turgay Kilic; Anna Koromyslova; Virginie Malak; Grant S Hansman
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

5.  Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.

Authors:  Anna D Koromyslova; Vasily A Morozov; Lisa Hefele; Grant S Hansman
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

6.  Structural Basis for Human Norovirus Capsid Binding to Bile Acids.

Authors:  Turgay Kilic; Anna Koromyslova; Grant S Hansman
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

7.  Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes.

Authors:  Lisa C Lindesmith; Jacob F Kocher; Eric F Donaldson; Kari Debbink; Michael L Mallory; Excel W Swann; Paul D Brewer-Jensen; Ralph S Baric
Journal:  J Infect Dis       Date:  2017-12-05       Impact factor: 5.226

8.  Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths.

Authors:  Ying Qian; Mohan Song; Ming Tan; Yutao Chen; Xuemei Li; Xi Jiang; Ming Xia; Jarek Meller; Zihe Rao
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

9.  Clinical importance of immunonutrition in infants: a review of the recent literature.

Authors:  Ji Sook Park
Journal:  Clin Exp Pediatr       Date:  2022-02-17

Review 10.  Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota.

Authors:  Shunhao Zhang; Tianle Li; Jing Xie; Demao Zhang; Caixia Pi; Lingyun Zhou; Wenbin Yang
Journal:  Microb Cell Fact       Date:  2021-05-28       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.